DCGI allows Biophore India to manufacture coronavirus drug Favipiravir API
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetails
Hyderabad: Biophore India Pharmaceuticals, a Hyderabad-based firm, has received license from the Drug Controller General of India (DCGI) to manufacture ...
Read moreDetailsNew Delhi: Biocon said Wednesday that its medical device to treat COVID-19 patient has received approval from the Drugs Controller ...
Read moreDetails
By Dilip Cherian The litany of extensions continues. The latest is Defence Secretary Rajesh Kumar Singh, whose tenure the Modi...
Read moreDetails
The angry young generation is rising in protest in India, France, Spain, Italy, Germany, Poland and Serbia, to name a...
Read moreDetails
Brazil has come as a surprise at a time when extreme Right parties in Europe, Latin America and elsewhere, helped...
Read moreDetails
The Director General of Indo-Tibetan Border Police (ITBP) Shatrujeet Kapur’s remark on 22 October that Indian and Chinese forces are...
Read moreDetails